Land: Storbritannia
Språk: engelsk
Kilde: VMD (Veterinary Medicines Directorate)
Infectious bronchitis virus
Zoetis UK Limited
QI01AD07
Infectious bronchitis virus
Oral solution
POM-V - Prescription Only Medicine – Veterinarian
Chickens
Live Viral Vaccine
Authorized
2005-04-15
Revised: August 2020 AN: 00620/2020 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Poulvac IB Primer 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Avian infectious bronchitis vaccine (live), freeze-dried. QUANTITATIVE COMPOSITION Active Ingredients Per dose Infectious bronchitis virus strain H120 10 3.0 – 10 5.4 EID 50 Infectious bronchitis virus strain D274 clone 10 3.0 – 10 5.4 EID 50 Excipients For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution _or_ spray solution after reconstitution of the freeze-dried vaccine in water. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens from one day of age. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of chickens to reduce upper respiratory tract infections caused by strains of the Massachusetts serotype and Dutch variant strains D207/D274. The onset of immunity is from 27 days post vaccination. Protection of chicks will be of approximately 16 weeks duration at which age the chickens may be vaccinated with an appropriate inactivated IBV vaccine product. 4.3 CONTRAINDICATIONS Do not use in sick chickens. Refer to sections 4.4 and 4.7. Revised: August 2020 AN: 00620/2020 Page 2 of 6 4.4 SPECIAL WARNINGS It is accepted that spray administration offers benefits over water administration in terms of ease of application and percentage of birds vaccinated. Nevertheless, greater secondary problems may result under certain management conditions. Spray vaccination should not be used if intercurrent infection is suspected. It is important to consult your veterinary adviser or Zoetis technical staff before using the spray technique. Efficacy against infectious bronchitis caused by the 4/91 (793B) UK variant IB strain has not been demonstrated. Maternally derived antibody (MDA) can interfere with the development of active immunity. Where it is likely that recent field infection or vaccination of the parent flock has stimulated a high antibody titre and consequently a high le Les hele dokumentet